These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6118104)

  • 1. Effects of 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD 1) on the central nervous system: (2) Effects on nigro-striatal dopaminergic neurons.
    Toide K; Kitazato K; Unemi N
    Arch Int Pharmacodyn Ther; 1981 Jul; 252(1):106-12. PubMed ID: 6118104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K; Unemi N; Segawa T
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione(FD-1) on the central nervous system: 1. Effects on monoamines in the brain.
    Toide K; Kitazato K; Unemi N
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):243-56. PubMed ID: 6778400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism, antitumor activity, and acute toxicity of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione by oral administration to animals.
    Fujii S; Nakamura Y; Takeda S; Morita K; Sato T; Marunaka T; Kawaguchi Y; Unemi N
    Gan; 1980 Feb; 71(1):30-44. PubMed ID: 6769737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of depletion of striatal dopamine by alpha-methyl-m-tyrosine.
    Uretsky NJ; Snodgrass SR; Lorenzo AV
    J Pharmacol Exp Ther; 1975 Dec; 195(3):465-79. PubMed ID: 490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C; Weiss M; Rostain JC
    Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat.
    Wood PL
    J Pharmacol Exp Ther; 1982 Sep; 222(3):674-9. PubMed ID: 6286931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
    J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of various amino acids on the modulation of dopamine release from nigro-striatal dopaminergic neurones.
    Giorguieff-Chesselet MF; Besson MJ; Cheramy A; Glowinski J
    J Physiol (Paris); 1979; 75(6):611-3. PubMed ID: 547062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
    Mytilineou C; Cohen G; Dembiec-Cohen D; Van Woert M; Hwang E
    J Neural Transm Suppl; 1983; 19():37-51. PubMed ID: 6321649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
    Villarán RF; Tomás-Camardiel M; de Pablos RM; Santiago M; Herrera AJ; Navarro A; Machado A; Cano J
    Neurotoxicology; 2008 Mar; 29(2):244-58. PubMed ID: 18093658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of 5-fluorouracil analogs on humoral and cell-mediated responses in mice: augmentation of delayed hypersensitivity response against picryl chloride by 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD-1), a new anti-tumor drug.
    Yamada Y; Miyauchi S; Unemi N
    J Clin Lab Immunol; 1980 Nov; 4(3):153-7. PubMed ID: 6451710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum.
    Katagiri N; Abe K; Kitabatake M; Utsunomiya I; Horiguchi Y; Hoshi K; Taguchi K
    Neuroscience; 2009 Jun; 160(4):820-8. PubMed ID: 19285542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine manipulation alters immediate-early gene response of striatal parvalbumin interneurons to cortical stimulation.
    Trevitt JT; Morrow J; Marshall JF
    Brain Res; 2005 Feb; 1035(1):41-50. PubMed ID: 15713275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.